# Methylene Blue in Early Septic Shock

> **NCT04446871** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hospital Civil de Guadalajara** · enrollment: 91 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** 0.9% sodium chloride
- **DRUG:** Methylene Blue

## Key facts

- **NCT ID:** NCT04446871
- **Lead sponsor:** Hospital Civil de Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-17
- **Primary completion:** 2020-12-10
- **Final completion:** 2021-01-25
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446871, "Methylene Blue in Early Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04446871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*